Invitation to presentation of BioArctic's third quarter report for July - September 2024 on November 14 at 9.30 a.m. CET
BioArctic AB (NASDAQ STOCKHOLM: BIOA B) has announced it will release its Q3 2024 report for July-September on November 14, 2024, at 08:00 CET. The company will host an audiocast with teleconference in English at 09:30 CET where CEO Gunilla Osswald and CFO Anders Martin-Löf will present the quarterly results and conduct a Q&A session. Participants can join via webcast or teleconference, with both options requiring pre-registration. The presentation will be available on-demand afterward on BioArctic's corporate website.
BioArctic AB (NASDAQ STOCKHOLM: BIOA B) ha annunciato che pubblicherà il suo rapporto del terzo trimestre 2024 per il periodo di luglio-settembre il 14 novembre 2024, alle 08:00 CET. L'azienda ospiterà un audiocast con teleconferenza in inglese alle 09:30 CET, dove il CEO Gunilla Osswald e il CFO Anders Martin-Löf presenteranno i risultati trimestrali e condurranno una sessione di domande e risposte. I partecipanti possono unirsi tramite webcast o teleconferenza, con entrambe le opzioni che richiedono una registrazione anticipata. La presentazione sarà disponibile on-demand successivamente sul sito web aziendale di BioArctic.
BioArctic AB (NASDAQ STOCKHOLM: BIOA B) ha anunciado que publicará su informe del tercer trimestre de 2024 para el período de julio a septiembre el 14 de noviembre de 2024 a las 08:00 CET. La compañía llevará a cabo un audiocast con teleconferencia en inglés a las 09:30 CET, donde la CEO Gunilla Osswald y el CFO Anders Martin-Löf presentarán los resultados trimestrales y realizarán una sesión de preguntas y respuestas. Los participantes pueden unirse a través de webcast o teleconferencia, siendo ambas opciones sujetas a registro previo. La presentación estará disponible bajo demanda posteriormente en el sitio web corporativo de BioArctic.
BioArctic AB (NASDAQ STOCKHOLM: BIOA B)는 2024년 3분기 보고서를 7월-9월 기간에 대해 2024년 11월 14일, CET 08:00에 발표할 것이라고 밝혔습니다. 회사는 CET 09:30에 CEO Gunilla Osswald와 CFO Anders Martin-Löf가 분기 결과를 발표하고 질의응답 세션을 진행하는 영어 오디오캐스트와 전화 회의를 개최할 것입니다. 참가자는 웹캐스트 또는 전화 회의로 참여할 수 있으며, 두 가지 옵션 모두 사전 등록이 필요합니다. 발표 후 BioArctic의 기업 웹사이트에서 주문형으로 볼 수 있습니다.
BioArctic AB (NASDAQ STOCKHOLM: BIOA B) a annoncé qu'il publiera son rapport du troisième trimestre 2024 pour la période de juillet à septembre le 14 novembre 2024 à 08h00 CET. L'entreprise organisera un audiocast avec téléconférence en anglais à 09h30 CET, où la PDG Gunilla Osswald et le CFO Anders Martin-Löf présenteront les résultats trimestriels et mèneront une séance de questions-réponses. Les participants peuvent se joindre via webcast ou téléconférence, les deux options nécessitant une préinscription. La présentation sera disponible à la demande par la suite sur le site web de l'entreprise BioArctic.
BioArctic AB (NASDAQ STOCKHOLM: BIOA B) hat angekündigt, dass der Q3 2024 Bericht für Juli-September am 14. November 2024 um 08:00 CET veröffentlicht wird. Das Unternehmen wird um 09:30 CET ein Audiocast mit Telekonferenz in Englisch veranstalten, bei dem CEO Gunilla Osswald und CFO Anders Martin-Löf die Quartalsergebnisse präsentieren und eine Fragerunde durchführen werden. Teilnehmer können entweder über Webcast oder Telekonferenz teilnehmen, wobei beide Optionen eine vorherige Registrierung erfordern. Die Präsentation wird anschließend auf der Unternehmenswebsite von BioArctic on-Demand zur Verfügung stehen.
- None.
- None.
In conjunction to the report, BioArctic invites investors, analysts, and media to an audiocast with teleconference (in English) on November 14, at 09:30 CET, where Gunilla Osswald, CEO, and Anders Martin-Löf, CFO, will present and comment on the third quarter report, followed by a Q&A-session.
If you wish to participate via webcast, please use the link below. Via the webcast you will be able to ask written questions.
Webcast: https://ir.financialhearings.com/bioarctic-q3-report-2024/register
If you wish to participate via teleconference, please register on the link below. After registration you will be provided with phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.
https://conference.financialhearings.com/teleconference/?id=50047208
The webcast will also be available on demand on BioArctic's corporate website https://www.bioarctic.se/en/section/investors/presentations/ after the presentation.
For more information, please contact:
Oskar Bosson, VP Communications and Investor Relations, BioArctic AB
E-mail: oskar.bosson@bioarctic.se
Tel: + 46 704 10 71 80
This information was submitted for publication at 08:30 a.m. CET on November 6, 2024.
About BioArctic AB
BioArctic AB (publ) is a Swedish research-based biopharma company focusing on treatments that can delay or stop the progression of neurodegenerative diseases. The company invented Leqembi® (lecanemab) – the world's first drug proven to slow the progression of the disease and reduce cognitive impairment in early Alzheimer's disease. Leqembi has been developed together with BioArctic's partner Eisai, who are responsible for regulatory interactions and commercialization globally. In addition to Leqembi, BioArctic has a broad research portfolio with antibodies against Parkinson's disease and ALS as well as additional projects against Alzheimer's disease. Several of the projects utilize the company's proprietary BrainTransporter™ technology, which has the potential to actively transport antibodies across the blood-brain barrier to enhance the efficacy of the treatment. BioArctic's B share (BIOA B) is listed on Nasdaq Stockholm Large Cap. For further information, please visit www.bioarctic.se.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Invitation to presentation of BioArctic’s third quarter report for July - September 2024 on November 14 at 9.30 a.m. CET |
View original content:https://www.prnewswire.com/news-releases/invitation-to-presentation-of-bioarctics-third-quarter-report-for-july---september-2024-on-november-14-at-9-30-am-cet-302297319.html
SOURCE BioArctic
FAQ
When will BioArctic (BIOA) release its Q3 2024 earnings report?
How can investors participate in BioArctic's (BIOA) Q3 2024 earnings call?
Who will present BioArctic's (BIOA) Q3 2024 earnings results?
